1-2 of 2
Maria J. Sayas, MD
Close
Sort by
Journal Articles

Preliminary Results of the Flugaza Trial: A Phase III Randomized, Open Label Study Comparing Azacytidine Versus Fludarabine and Cytarabine (FLUGA Scheme) in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Pau Montesinos, MD PhD, Susana Vives, MD, Maria P Martinez-Sanchez, MD, Juan Bergua, MD, Lorenzo Algarra, MD, Herrera Pilar, MD, Mar Tormo, MD, Jose-Luis Lopez-Lorenzo, MD, Fernando Ramos, MD, Jose Francisco Falantes, MD, Olga Salamero, MD, Josefina Serrano, MD, Cristina Gil, MD, Maria L Amador, MD, Esperanza Lavilla, MD, Maria J Sayas, MD, Maria Teresa Olave, MD, Belen Vidriales, MD, David Martínez-Cuadrón, MD PhD, Miguel Ángel Sanz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4036.
https://doi.org/10.1182/blood.V128.22.4036.4036
Published: 2016
Journal Articles

Autologous Stem Cell Transplantation after FLAG-IDA Chemotherapy for High-Risk Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemias Secondary to MDS (sAML) Does Not Improve Outcome: A PETHEMA Experience in 103 Patients.

Guillermo F. Sanz, MD, Armando V. Mena-Duran, MD, Jose M. Ribera, MD, Teresa Bernal, MD, Luis Palomera, MD, Maria C. del Cañizo, MD, Mar Tormo, MD, Maria J. Sayas, MD, Raimundo García-Boyero, MD, Javier de la Serna, MD, Manuel Pérez-Encinas, MD, Montserrat Pérez-Sánchez, MD, María J. Arilla, MD, Juan J. Moneva, MD, Maria L. Amigo, MD, Luis Benlloch, Montserrat Batlle, MD, Consuelo Rayon, MD
Journal: Blood
Blood (2005) 106 (11): 793.
https://doi.org/10.1182/blood.V106.11.793.793
Published: 2005